Detalhe da pesquisa
1.
Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).
J Am Acad Dermatol
; 84(2): 398-407, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961255
2.
Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.
J Am Acad Dermatol
; 84(2): 432-470, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32738429
3.
Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2).
J Drugs Dermatol
; 20(8): 880-887, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34397207
4.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
J Am Acad Dermatol
; 82(1): 161-201, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703821
5.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
J Am Acad Dermatol
; 82(6): 1445-1486, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119894
6.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
N Engl J Med
; 375(4): 345-56, 2016 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27299809
7.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
J Am Acad Dermatol
; 80(4): 1073-1113, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772097
8.
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
J Am Acad Dermatol
; 80(4): 1029-1072, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772098
9.
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.
J Am Acad Dermatol
; 81(3): 775-804, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31351884
10.
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2).
J Am Acad Dermatol
; 79(2): 302-314.e6, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660421
11.
Highlights of Skin Disease Education Foundations 42nd Annual Hawaii Dermatology Seminar.
Semin Cutan Med Surg
; 37(4S): S75-S84, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016379
12.
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
J Am Acad Dermatol
; 76(2): 290-298, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908543
13.
Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™.
Semin Cutan Med Surg
; 36(4S): S52-S59, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28745729
14.
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis.
J Am Acad Dermatol
; 75(1): 83-98.e4, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27180926
15.
Reduction in C-Reactive-Protein Levels With Adalimumab Therapy in Patients With Moderate-to-Severe Hand and/or Foot Psoriasis.
J Drugs Dermatol
; 15(5): 562-6, 2016 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27168265
16.
Small Molecules for Psoriasis.
Semin Cutan Med Surg
; 35(4S): S65-S66, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29850659
17.
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
Semin Cutan Med Surg
; 35(4S): S74-S77, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29850661
18.
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
Semin Cutan Med Surg
; 35(4 Suppl 4): S74-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27551698
19.
New Therapies for Psoriasis.
Semin Cutan Med Surg
; 35(4 Suppl 4): S71-3, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525355
20.
Small Molecules for Psoriasis.
Semin Cutan Med Surg
; 35(4 Suppl 4): S65-6, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525564